Dr. Alexander Laubach holds a PhD in chemistry and leads the business field development for medical devices at Hohenstein Laboratories.
Prior to his current role, he worked in various analytical laboratories in regulated environments. As a department head for sample preparation and instrumental analytics, he handled testing of consumer goods, food contact materials, and medical devices. In recent years, his work has increasingly focused on medical device safety, particularly in advancing biocompatibility testing.
At Hohenstein Laboratories—an ISO 17025-accredited and GLP-certified testing facility—he continues to develop chemical, physical, and biological testing methods focusing on general safety and performance requirements according to the Medical Device Regulation (MDR 2017/745) with an emphasis on biocompatibility testing according to ISO 10993 and ISO 18562.
What matters most to him as a speaker: "Every biocompatibility assessment starts with chemical characterization (ISO 10993-18), and I’m aware that chemistry isn’t everyone’s favorite subject. As a chemist, I aim to eliminate the fear and uncertainty around chemical analysis, explaining it in accessible terms. A complete chemical characterization, combined with a scientifically sound toxicological risk assessment, is the key to robust biocompatibility evaluation."